Healthy Returns: A key step forward for Novo Nordisk's GLP-1 pill ⊕
A closely watched pill from Novo Nordisk just scored an approval for slashing cardiovascular risks, while Mark Cuban gives Trump credit on drug prices.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.